ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE:

Almus product wins Pharmacy Product of the Year 2023

 

Alliance Healthcare are proud and delighted to share that our own brand product, Almus Erectile Dysfunction Relief 50mg Film Coated Tablets, won Pharmacy Product of the Year 2023 (Sexual Health category) as voted by independent pharmacists in the UK. 

 

Run by the Independent Community Pharmacist magazine (part of the Communications International Group), the Pharmacy Product of the Year Awards celebrates their 13th year of recognising exceptional brands and their commitment to independent pharmacies as they strive to improve the service they offer to their patients. Independent pharmacists and, for the first time, consumers, have voted on the most popular and best-selling over the counter products in a range of categories in independent pharmacies across the country.

ed2PPOY

Tara Dew, Own Brand Manager says: “This is fantastic news for our own brand Almus OTC, and just shows how much we’ve grown as a brand over the last few years. This success follows on from last year’s MVP Awards, which the product was shortlisted for Most Valued Product of the Year 2022, together with Almus Ibuprofen and Codeine 200mg/12.8mg Tablets (32s) and Almus Cold Sore 1% w/w Cream”.

 

Click here to view the March issue of ICP magazine.

 

You can also view the full Pharmacy Product of the Year Winners feature here.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Briviact 75mg & 100mg film coated tablets

Ethigen Limited have informed the MHRA that the Patient Information Leaflet (PIL) in Briviact 75mg and Briviact 100mg film coated tablets contains incorrect or missing information.

 

MHRA drug alert date: 30th March 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ethigen-limited-briviact-75mg-and-100mg-film-coated-tablets-el-23-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=029a9973-e8e8-4dc1-99ae-a45b0b7f8b12&utm_content=immediately

 

 

Pip code

Product Description

Affected Batches

ALLIANCE HEALTHCARE DO NOT STOCK

BRIVIACT FILM COATED TABS 75MG

340132       332075

ALLIANCE HEALTHCARE DO NOT STOCK

BRIVIACT FILM COATED TABS 100MG

332076

329941

337225

332072

329491

337216

339975

337216

343194

349497

343190

349527

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For medical information and stock control queries please contact the Regulatory Affairs Department at regulatory@ethigen.co.uk.

 

SUB-TYPE:

Alliance Healthcare UK to enter into a new solus wholesale agreement with Daiichi Sankyo: 01 May 2023

 

We are pleased to announce that, as of 01 May 2023, Alliance Healthcare UK will become the only wholesaler to supply Daiichi Sankyo’s product portfolio* to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland.

 

*ENHERTU will remain in its present distribution arrangement outside of this solus agreement.

 

Click here for full product details.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall-GONAPEPTYL Depot 3.75mg

Reason: “Ferring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked 30-millimeter (30mm) needle for subcutaneous injection that is supplied with each product pack.”

 

MHRA drug alert date  23rd March 2023

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-ferring-pharmaceuticals-limited-gonapeptyl-depot-3-dot-75mg-powder-and-solvent-for-suspension-for-injection-el-23-a-slash-12

 

  • MHRA ref: MDR 065-03/23

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE HEALTHCARE DO NOT STOCK

GONAPEPTYL DEPOT PFS 3.75MG    

FERRING PHARMACEUTICALS

T16656K
U11271E
U11271F
U11386G
U11570E
U11571E
U15102C
U15102K
U15102L

 

Further Information

For all medical enquiries, please contact medical information: medical.uk@ferring.com.

For supply queries, please contact customer services: customer.services@ferring.com

 

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall - Sildenafil 10mg/ml Oral Suspension

CLASS 3 RECALL -  SILDENAFIL 10MG/ML ORAL SUSPENSION

 

Rosemont Pharmaceuticals Limited has informed the MHRA that the Press In Bottle Adaptor (PIBA) supplied with the pack (carton) in the batch listed above is too wide to fit the neck of the medicine.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-rosemont-pharmaceuticals-limited-sildenafil-10mg-slash-ml-oral-suspension-el-23-a-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7d86bb08-f180-4501-855c-2a3380963267&utm_content=immediately

Pip code

Product description

Supplier

Batch numbers

8045130

Sildenafil 10mg/ml Oral Suspension

Rosemont Pharmaceuticals Limited

SLD22002

 

For more information, medical information queries or replacement PIBA enquiries, please contact: pharmacovigilance@rosemontpharma.com.

 

For stock control queries, please contact: customerservices@rosemontpharma.com.

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

 

 

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Venlafaxine 150, 225 and 300mg XL tablets-Martindale brand

Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/47), Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product (Venlalic® XL prolonged-release tablets).

 

MHRA drug alert date: 16th March 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-macarthys-laboratories-t-slash-a-martindale-pharma-venlafaxine-xl-150mg-225mg-300mg-prolonged-release-tablets-el-23-a-slash-10?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=466f420a-5cf3-4fcc-8f9d-043cf1141af8&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

1257583

VENLAFAXINE XL TAB 150MG

MARTINDALE PHARMA

LC70019   LC70020

 

8045304

VENLAFAXINE XL TAB 150MG

MARTINDALE PHARMA

LC70019   LC70020

 

8047326

VENLAFAXINE XL TAB 225MG

MARTINDALE PHARMA

LC70053   LC70054

 

1257567

 

VENLAFAXINE XL TAB 225MG

MARTINDALE PHARMA

LC70053   LC70054

 

8045312

VENLAFAXINE XL TAB 225MG

MARTINDALE PHARMA

LC70053   LC70054

 

8047318

VENLAFAXINE XL TAB 300MG

MARTINDALE PHARMA

LC69693   LC69699   LC69701

 

1257559

 

VENLAFAXINE XL TAB 300MG

MARTINDALE PHARMA

LC69693   LC69699   LC69701

 

8045320

VENLAFAXINE XL TAB 300MG

MARTINDALE PHARMA

LC69693   LC69699   LC69701

 

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For further information, medical enquiries and stock information, contact: Licensed@ethypharm.com.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall- All Pholcodine containing products

Reason: Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution.

 

MHRA drug alert date: 14/03/23

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-various-marketing-authorisation-holders-pholcodine-containing-products-el-23-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=61c43c8f-6aa7-4d2a-a81b-73bece5741ba&utm_content=immediately#brief-description-of-the-problem

 

MHRA ref: MDR 008-12/22

 

Pip code

Product Description

Affected Batches

1031228

CARE PHOLCODINE LINCTUS

ALL

2964625

CARE PHOLCODINE LINCTUS S/F

ALL

0235218

GALENPHOL LINC 5MG/5ML

ALL

0235309

GALENPHOL STRNG LINC 10MG/5ML

ALL

3772340

COVONIA DRY COUGH SUGAR FREE

ALL

7013279

PHOLCODEINE SF STRONG 10MG/5ML

ALL

2881290

DAY & NIGHT NURSE CAP

ALL

0076083

DAY NURSE CAP

ALL

2831527

DAY NURSE LIQUID

ALL

6288377

SUPERDRUG PHOLCODINE LINCTUS

ALL

Alliance Healthcare do not stock

Boots Night Cough Relief Oral Solution

ALL

Alliance Healthcare do not stock

Boots Dry Cough Syrup 6 Years+

ALL

Alliance Healthcare do not stock

Boots Day Cold & Flu Relief Oral Solution

ALL

Alliance Healthcare do not stock

Pholcodine Linctus (LCM brand)

ALL

Alliance Healthcare do not stock

Pholcodine Linctus BP (Pinewood brand)

ALL

Alliance Healthcare do not stock

Strong Pholcodine Linctus BP (pinewood brand)

ALL

Alliance Healthcare do not stock

Pholcodine Linctus Bells Healthcare 5mg Per 5ml Oral Solution

ALL

Alliance Healthcare do not stock

Numark Pholcodine 5mg per 5ml Oral Solution

ALL

Alliance Healthcare do not stock

Well Pharmaceuticals Pholcodine 5mg per 5ml Oral Solution

ALL

Alliance Healthcare do not stock

Strong Pholcodine Linctus BP (Bells brand)

ALL

Alliance Healthcare do not stock

Galenphol Paediatric Linctus

ALL

 

 

Further Information

For more information or, medical enquiries, please contact the respective companies below:

 

The Boots Company PLC

Boots Customer Care:

Telephone: 0345 0708090

 

Thornton & Ross Limited / LCM Limited

Telephone: 01484 848164

Email: thorntonross@medinfomation.co.uk

 

Bell Sons & Company (Druggists) Limited

Qualified Person for Pharmacovigilance (QPPV): Mr Trevor Price:

Telephone: 0151 422 1216 / mobile: 07739 327 095

Email: trevor.price@bells-healthcare.com

 

Pinewood Laboratories Limited

Drug Safety & Information department, Wockhardt UK Limited:

Email: drug.safety@wockhardt.co.uk

Telephone: 01978 661261

 

Glaxosmithkline Consumer Healthcare (UK) Trading Limited

Contact Haleon consumer services:

Telephone: 0800 783 8881

Email: mystory.gb@haleon.com.

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: COMPANY-LED RECALL

company-led recall: Sylk vaginal lubricant

Sylk ltd has informed us Mould has been reported in some of the retail bottles. The affected batches were distributed to retailers in the United Kingdom from mid-2022 onwards

 

PIP CODE

DESCRIPTION

SUPPLIER

AFFECTED BATCHES

3149689

SYLK VAGINAL LUBRICANT NAT

SYLK LTD MD           

BT3579 BT3691 BT3803 BT3915

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Clexane 10,000 IU (100mg) / 1ml Syringes

Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the leaflet.

 

MHRA drug alert date: 9th March 2023

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-drugsrus-limited-clexane-10000-iu-100mg-slash-1ml-syringes-el-23-a-slash-08

 

Pip code

Product

Supplier

Affected Batches

Alliance healthcare do not stock

Clexane 10,000IU (100mg)/1 ml Syringes

STAR PHARMACUETICALS LTD

ECD95D

Alliance healthcare do not stock

Clexane 10,000IU (100mg)/1 ml Syringes

TENOLOL LTD

ECI41A

FCA45G

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For more information, medical information queries or replacement PIL enquiries, please contact: recall@drugsrus.co.uk or 020 8423 3800. For stock control queries, please contact: info@drugsrus.co.uk or 020 8423 3800

SUB-TYPE:

Alliance Healthcare UK to supply TRANSTEC in a solus wholesale agreement with Grünenthal: March 2023

 

We are pleased to announce that Alliance Healthcare UK is now the only wholesaler to supply TRANSTEC to all pharmacies, hospitals and dispensing doctors in the United Kingdom, including Northern Ireland. TRANSTEC has been acquired by Grünenthal from Napp Pharmaceuticals.

 

Click here for full product details.